美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

NewLink Genetics Corp.

0.8900

0.0000

成交量：- -

成交额：- -

市值：3,319.70万

市盈率：-0.77

高：0.8900

开：0.8900

低：0.8900

收：0.8900

52周最高：3.60

52周最低：0.8403

股本：3,730.00万

流通股本：2,285.43万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.1500

每股收益(LYR):-1.1527

净资产收益率：-44.31%

总资产收益率：-21.70%

市净率：0.42

市盈率(LYR):-0.77

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

NewLink Genetics Corp.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.newlinkgenetics.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Newlink Genetics Corporation是一家生物制药公司，专注于发现、开发和商业化免疫治疗产品，改善癌症患者的治疗方案。公司的产品包括生物和小分子免疫治疗候产品。公司的生物产品是基于公司的专有超急性免疫治疗技术，其目的是刺激人体免疫系统。公司的小分子产品的重点是通过抑制吲哚胺-(2、3)-加双氧酶途径打破癌症免疫系统的容忍度。公司相信公司免疫治疗技术有可能产生多个产品针对广泛的肿瘤症状治疗，其可以单独或结合其他疗法进行治疗。该公司于1999年6月4日以NewLink Genetics Corporation为名在特拉华州成立。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NLNK/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NLNK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLNK\",,,,,undefined,":{"symbol":"NLNK","market":"US","secType":"STK","nameCN":"NewLink Genetics Corp.","latestPrice":0.89,"timestamp":1584561600000,"preClose":0.89,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":22854328,"shares":37300000,"eps":-1.15,"marketStatus":"盘前交易","change":0,"latestTime":"03-26 04:01:36 EDT","open":0.89,"high":0.89,"low":0.89,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.15,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774531800000},"marketStatusCode":1,"symbolChange":{"newSymbol":"LUMO","executeDate":"2020-03-19"},"adr":0,"adrRate":0,"listingDate":1320987600000,"exchange":"NASDAQ","adjPreClose":0.89,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLNK\",,,,,undefined,":{"symbol":"NLNK","floatShares":22854328,"roa":"-21.70%","roe":"-44.31%","lyrEps":-1.152689,"shares":37300000,"dividePrice":0,"high":0.89,"amplitude":0,"preClose":0.89,"low":0.89,"week52Low":0.8403,"pbRate":"0.42","week52High":3.6,"institutionHeld":0,"latestPrice":0.89,"eps":-1.15,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.15,"open":0.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NLNK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-03-19","symbol":"NLNK","oldSymbol":"NLNK","newSymbol":"LUMO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1584590400000},{"market":"US","date":"2020-03-19","symbol":"NLNK","type":"split","dateTimestamp":1584590400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2020-02-28","symbol":"NLNK","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盘前","type":"earning","dateTimestamp":1582866000000,"reportTimeType":"pre","actualEps":-1.98},{"date":"2019-11-06","symbol":"NLNK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.27,"defaultRemindTime":1573030800000,"name":null,"time":"盘前","dateTimestamp":1573016400000,"actualEps":null},{"market":"US","date":"2019-05-08","symbol":"NLNK","fiscalQuarterEnding":"2019/03","expectedEps":-0.31,"name":null,"time":"盘后","type":"earning","dateTimestamp":1557288000000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NLNK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NLNK\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.newlinkgenetics.com","stockEarnings":[{"period":"1week","weight":-0.8889},{"period":"1month","weight":-0.8889},{"period":"3month","weight":-0.8889},{"period":"6month","weight":-0.8889},{"period":"1year","weight":-0.8889},{"period":"ytd","weight":-0.8889}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Newlink Genetics Corporation是一家生物制药公司，专注于发现、开发和商业化免疫治疗产品，改善癌症患者的治疗方案。公司的产品包括生物和小分子免疫治疗候产品。公司的生物产品是基于公司的专有超急性免疫治疗技术，其目的是刺激人体免疫系统。公司的小分子产品的重点是通过抑制吲哚胺-(2、3)-加双氧酶途径打破癌症免疫系统的容忍度。公司相信公司免疫治疗技术有可能产生多个产品针对广泛的肿瘤症状治疗，其可以单独或结合其他疗法进行治疗。该公司于1999年6月4日以NewLink Genetics Corporation为名在特拉华州成立。","exchange":"NASDAQ","name":"NewLink Genetics Corp.","nameEN":"NewLink Genetics Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NLNK\",market:\"US\",,,undefined,":null}}